Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV. (Q45885655)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

1 reference

based on heuristic

inferred from title

author name string

Xin KQ

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

Jounai N

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

Someya K

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

Honma K

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

Mizuguchi H

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

Naganawa S

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

Kitamura K

7

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

Hayakawa T

8

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

Saha S

9

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

Takeshita F

10

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

Okuda K

11

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

Honda M

12

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

Klinman DM

13

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

Okuda K

14

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

publication date

1 December 2005

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

12

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

24

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

1769-1777

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302590

0 references

Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Recombinant rabies virus as potential live-viral vaccines for HIV-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Venezuelan equine encephalitis virus vectors expressing HIV-1 proteins: vector design strategies for improved vaccine efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Oral administration of recombinant adeno-associated virus elicits human immunodeficiency virus-specific immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Development of a preventive vaccine for Ebola virus infection in primates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Progress and problems with the use of viral vectors for gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Human adenovirus type 35: nucleotide sequence and vector development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

CD46 is a cellular receptor for group B adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Development of adenovirus serotype 35 as a gene transfer vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Replication-defective vector based on a chimpanzee adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Circumvention of vector-specific neutralizing antibody response by alternating use of human and non-human adenoviruses: implications in gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Optical imaging of Renilla luciferase reporter gene expression in living mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

An infectious DNA clone of HIV type 1 subtype C.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Construction and characterization of an infectious molecular clone derived from the CRF01_AE primary isolate of HIV type 1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

21 January 2018

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

7 January 2021

based on heuristic

inferred from DOI database lookup

Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

7 January 2021

based on heuristic

inferred from DOI database lookup

Contribution of the rev gene to the immunogenicity of DNA vaccines targeting the envelope glycoprotein of HIV

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

7 January 2021

based on heuristic

inferred from DOI database lookup

Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302590

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3302590

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16079886

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45885655&oldid=1465752387"